- Trimetazidine Dihydrochloride IP 35mg.
INDICATIONS :
Trimetazidine is an anti-ischemic (anti-anginal) metabolic agent, which improves myocardial glucose utilization through inhibition of fatty acid metabolism, also known as fatty acid oxidation inhibitor.
- As directed by the physician.`